Teachers Advisors’s Denali Therapeutics DNLI Stock Holding History

Teachers Advisors’s Portfolio DNLI Stock Details DNLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$2.37M	Buy	102,114 +2,902	+3%	+$60.7K	﹤0.01%	1879
2018 Q4	$2.05M	Buy	99,212 +6,541	+7%	+$119K	﹤0.01%	1832
2018 Q3	$2.02M	Buy	92,671 +57,863	+166%	+$957K	﹤0.01%	1977
2018 Q2	$531K	Buy	34,808 +4,810	+16%	+$90.6K	﹤0.01%	2628
2018 Q1	$591K	Buy	+29,998	New	+$617K	﹤0.01%	2455

Other funds holding DNLI

Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Teachers Advisors's DNLI Position: Q1 2019 in Review

Teachers Advisors increased its Denali Therapeutics (DNLI) stake by 2.9% in Q1 2019, buying an estimated $60.7K and bringing the position to 102,114 shares worth $2.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1879.

Teachers Advisors first reported a position in DNLI in Q1 2018 and has held it in 5 quarters since. 114 funds tracked by Wall St. Rank hold DNLI as of Q1 2019.

Teachers Advisors held 102,114 shares of Denali Therapeutics worth $2.37M as of Q1 2019.
Teachers Advisors bought 2,902 Denali Therapeutics shares in Q1 2019, an estimated $60.7K.
Denali Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1879 holding.
Teachers Advisors first reported a position in Denali Therapeutics in Q1 2018 and has held it in 5 quarters since.
114 funds tracked by Wall St. Rank held Denali Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.